Metraipolis › archive › dc_9293b0ca5732

Efficacy and safety of antibody-drug conjugates for HER2-expressing advanced gastric and gastroesophageal junction adenocarcinoma: a systematic review and… — Europe PMC PMID:41041636

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41041636
DOI
10.3389/fphar.2025.1668511
License (as archived)
solo-consultazione
Archived
2026-11-09T22:13:47.553Z
SHA-256 of the archived text
826b053427b6df574db73ad5c1da12e4e0f479a6c1bdc4e8b9f267fac906113c
Stable URL of this page
https://metraipolis.com/documento/dc_9293b0ca5732

How to cite

Efficacy and safety of antibody-drug conjugates for HER2-expressing advanced gastric and gastroesophageal junction adenocarcinoma: a systematic review and… — Europe PMC PMID:41041636 — Europe PMC (en), https://europepmc.org/article/MED/41041636 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9293b0ca5732 (Metraipolis archive dc_9293b0ca5732, sha256 826b053427b6df574db73ad5c1da12e4e0f479a6c1bdc4e8b9f267fac906113c)
BibTeX
@misc{dc9293b0ca5732,
  title = {Efficacy and safety of antibody-drug conjugates for HER2-expressing advanced gastric and gastroesophageal junction adenocarcinoma: a systematic review and… — Europe PMC PMID:41041636},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41041636},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9293b0ca5732; sha256 826b053427b6df574db73ad5c1da12e4e0f479a6c1bdc4e8b9f267fac906113c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41041636. Agents can read the archived copy with the MCP tool read_document.